This was originally published on Global Health TV on April 25, 2017.
When I was a
young development worker, I engaged in high risk behavior one night in a
village in Mali: I slept without a mosquito net. A week or so later I
contracted malaria.
Of all the
diseases I have written about here, malaria is the only one with which I have
personal and intimate experience. And it was not pleasant. It was so
debilitating, so sapping of my energy, I remember not caring whether I lived or
died.
Fortunately, I was
an otherwise healthy young male and bounced back briskly after a week or so of
misery. In fact, I have lived long enough to see the beginning of the end (or
at least the decline) of this global killer: In December, the World Health
Organization (WHO) released the World Malaria Report 2016 in which it estimated that 1.3 billion
fewer malaria cases and 6.8 million fewer malaria deaths occurred between 2001
and 2015 than would have occurred had incidence and mortality remained the
same. About 97% of those deaths averted were for children under five years (who
are most vulnerable to the disease, along with pregnant women).
Buried on Page
50 of the report is the gist of what makes this news so exciting: In WHO’s
Africa Region, these reduced malaria mortality rates have translated to a rise
in life expectancy at birth of 1.2 years, accounting for 12% of the total
increase in life expectancy of 9.4 years, from 50.6 years in 2000 to 60 in
2015.
This means more
children — many more children — will survive the perils of childhood in Africa
and go on to lead productive lives as adults. This makes malaria control one of
the most exciting developments of many encouraging global health trends in
recent years.
Today we mark World Malaria Day with the message “Let’s close the gap”
in malaria prevention. It’s a time to celebrate the tremendous accomplishments
to date, but also to remember how many challenges remain. For example, an
estimated 43% of people at risk in sub-Saharan Africa are still not protected
from malaria, according to WHO. And there were still 212 million cases of
malaria worldwide in 2015.
Dr. Richard
Cibulskis, coordinator of Evidence and Economics of the WHO Global Malaria
Programme, told Global Health TV that we have good reason to be optimistic
about the fight against malaria.
“We’ve
had huge success in bringing down malaria incidence and mortality rates over
the last fifteen years. We have effective tools to prevent, diagnose and treat
the disease, and coverage of these tools has been massively scaled up in many
countries. There are exciting new technologies under development, and more
countries than ever are making progress towards elimination.”
“But there are also some worrying trends, especially the
fact that global funding seems to be flat-lining. We can eliminate malaria, but
only if we can continue to harness the financial and political will needed to
accelerate progress and make new and existing tools available to all who need
them.”
Insecticide-treated
bed nets are one of the biggest successes in malaria control. The World Malaria
Report found that 53% of the population at risk in Sub-Saharan Africa slept
under a net in 2015 compared to 30% in 2010. Furthermore, WHO found that people
who slept under nets had significantly lower rates of malaria infection than
those who did not use a net.
And it
was announced yesterday
that the world’s first vaccine against malaria will be tested in Ghana, Kenya
and Malawi in 2018. The vaccine has the potential to save tens of thousands of
lives but it is unclear if it is feasible to get parents to bring their babies
in four separate times to get the required doses.
Malaria control
has had solid bipartisan support in the U.S. for 15 years. The U.S. government
– the largest donor to global malaria efforts – has increased its support from
$146 million in 2001 to $861 million in 2016. Funding really took off after former
U.S. President George W. Bush launched the President’s Malaria Initiative in 2005.
Last month, U.S.
President Donald Trump released a proposed budget that calls for close to a
one-third reduction in foreign assistance. We don’t know how those cuts – which
still have to be approved by a dubious Congress – would affect malaria control
but it does cause concern.
What we do know
is that President Trump has announced plans to meet U.S. commitments to the
Global Fund for AIDS, TB and Malaria, according to this analysis by Friends of the Global Fight.
The WHO’s
Global Technical Strategy for Malaria calls for malaria to be eliminated
in at least 35 countries by 2030. Dr. Cibulskis call this “an ambitious but
achievable target.”
“But even if this target is achieved, it could still leave
us with more than 50 countries in which malaria is endemic,” he says. “A
challenge will be maintaining robust funding and political commitment as we
continually make progress towards this goal.”
One of the problems the malaria control community worries about
is that once cases and deaths have decreased and the disease seems like less of
a threat, funding for malaria could be cut.
“History has shown us that we must keep our levels of
investment high, or risk a resurgence of the disease and a reversal of progress
made to date,” says Dr. Cibulskis. “We cannot let up in our efforts until we
get the job done.”
No comments:
Post a Comment